Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Lemaitre Vascular (LMAT)

Lemaitre Vascular (LMAT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 805,136
  • Shares Outstanding, K 20,342
  • Annual Sales, $ 117,230 K
  • Annual Income, $ 17,930 K
  • 60-Month Beta 1.34
  • Price/Sales 7.16
  • Price/Cash Flow 35.33
  • Price/Book 5.19
Trade LMAT with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate 0.31
  • Number of Estimates 3
  • High Estimate 0.32
  • Low Estimate 0.30
  • Prior Year 0.23
  • Growth Rate Est. (year over year) +34.78%

Price Performance

See More
Period Period Low Period High Performance
1-Month
32.56 +20.98%
on 11/02/20
41.86 -5.90%
on 11/25/20
+6.91 (+21.27%)
since 10/30/20
3-Month
30.03 +31.17%
on 09/14/20
41.86 -5.90%
on 11/25/20
+7.70 (+24.30%)
since 08/28/20
52-Week
18.76 +109.97%
on 03/23/20
41.86 -5.90%
on 11/25/20
+3.82 (+10.74%)
since 11/29/19

Most Recent Stories

More News
Zacks.com featured highlights include: Shutterstock, Winnebago Industries, LeMaitre and Logitech

Zacks.com featured highlights include: Shutterstock, Winnebago Industries, LeMaitre and Logitech

LOGI : 90.30 (+3.85%)
SSTK : 68.76 (+0.23%)
LMAT : 39.39 (-0.48%)
WGO : 52.93 (-0.79%)
Shares of LMAT Up 45.6% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Lemaitre Vascula (NASDAQ:LMAT) on July 22nd, 2020 at $28.51. In approximately 4 months, Lemaitre Vascula has returned 45.55% as of today's recent price of $41.49.

LMAT : 39.39 (-0.48%)
4 Promising Top-Ranked Liquid Stocks to Boost Your Portfolio

Here are four top-ranked liquid stocks, Winnebago Industries (WGO), Shutterstock (SSTK), Logitech (LOGI), and LeMaitre Vascular (LMAT), that investors can snap up for a winning portfolio.

LOGI : 90.30 (+3.85%)
SSTK : 68.76 (+0.23%)
LMAT : 39.39 (-0.48%)
WGO : 52.93 (-0.79%)
Lemaitre Vascula Up 36.1% Since SmarTrend Uptrend Call (LMAT)

SmarTrend identified an Uptrend for Lemaitre Vascula (NASDAQ:LMAT) on July 22nd, 2020 at $28.51. In approximately 4 months, Lemaitre Vascula has returned 36.08% as of today's recent price of $38.79.

LMAT : 39.39 (-0.48%)
3 Reasons Why Growth Investors Shouldn't Overlook LeMaitre (LMAT)

LeMaitre (LMAT) is well positioned to outperform the market, as it exhibits above-average growth in financials.

LMAT : 39.39 (-0.48%)
Agios' (AGIO) Mitapivat Gets Orphan Drug Tag to Treat SCD

The FDA confers an orphan drug status on Agios' (AGIO) pyruvate kinase-R activator mitapivat for addressing sickle cell disease. Stock climbs in after-hours trading.

OMI : 25.76 (+3.41%)
BIO : 538.50 (+0.64%)
LMAT : 39.39 (-0.48%)
AGIO : 46.32 (+3.69%)
LeMaitre Vascular to Present at the Jefferies Virtual London Healthcare Conference

LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at Jefferies Virtual London Healthcare Conference on Wednesday, November 18, 2020, at 12:25 PM ET.

LMAT : 39.39 (-0.48%)
Uptrend Call Working As Lemaitre Vascula Stock Rises 30.5% (LMAT)

SmarTrend identified an Uptrend for Lemaitre Vascula (NASDAQ:LMAT) on July 22nd, 2020 at $28.51. In approximately 4 months, Lemaitre Vascula has returned 30.50% as of today's recent price of $37.20.

LMAT : 39.39 (-0.48%)
Boston Scientific (BSX) in Focus: Stock Moves 7% Higher

Boston Scientific (BSX) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.

BSX : 33.15 (-1.34%)
LMAT : 39.39 (-0.48%)
LeMaitre Vascular to Present at Upcoming Investor Conferences

LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two investor conferences in November.

LMAT : 39.39 (-0.48%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and...

See More

Key Turning Points

2nd Resistance Point 40.42
1st Resistance Point 39.90
Last Price 39.39
1st Support Level 38.97
2nd Support Level 38.56

See More

52-Week High 41.86
Last Price 39.39
Fibonacci 61.8% 33.04
Fibonacci 50% 30.31
Fibonacci 38.2% 27.58
52-Week Low 18.76

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar